Regulatory Post Marketing Surveillance Study in Korea

• Status: Completed
• Trial end date: 2017-08-11
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of the study is to investigate and collect post marketing data on the safety and efficacy of Visanne at follow-up visit after about 6 months of treatment and - for a subset of patients - at optional long-term follow-up visit after about 1 year of treatment under daily practice treatment conditions in Korean women and to obtain data on drug utilization on treatment for endometriosis.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Dienogest

Criteria

Inclusion Criteria:

• Signed and dated informed consent

• Women diagnosed by a physician as having endometriosis

• Women who are prescribed Visanne(dienogest 2mg)for the first time during the study period

Exclusion Criteria:

• All contraindications according to the local marketing authorization have to be considered.